Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

Phase 3

Completed

• Conditions: Dry Eye

• Registration Number: NCT00471419
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07
• Study First Submitted: 2007-05-07
• Study First Submitted QC: 2007-05-07
• Study First Posted: 2007-05-09
• Primary Completion: 2007-08
• Study Completion: 2007-08
• Status Verified: 2008-03
• Last Update Submitted: 2012-06-03
• Last Update Posted: 2012-06-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

• documented dry eye history
• ocular symptoms
• tear use
• dry eye ocular signs

Exclusion Criteria

• Under 18

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Corneal staining; dry eye sympton	Immediate

Secondary Outcome Measures

Name	Time	Method
Corneal staining; dry eye sympton	Prolonged

Trial Locations

Locations (1)

Cleveland; 🇺🇸 Cleveland, Ohio, United States